The main function of fibroblast growth factor 23 (FGF23) is the regulation of phosphate metabolism through its action on the sodium-dependent phosphate cotransporters in the proximal renal tubules. Additionally, FGF23 interacts with vitamin D and parathyroid hormone in a complex metabolic pathway whose detailed mechanisms are still not clear in human physiology and disease. More recently, research has also focused on the understanding of mechanisms of FGF23 action on organs and system other than the kidneys and bone, as well as on its interaction with other metabolic pathways. Collectively, the new evidence are successfully used for the clinical evaluation and management of FGF23-related disorders, for whom which new therapies with many potential applications are now available.

FGF23 functions and disease / Cipriani, Cristiana; Minisola, Salvatore; Colangelo, Luciano; DE Martino, Viviana; Ferrone, Federica; Biamonte, Federica; Danese, Vittoria; Sonato, Chiara; Santori, Rachele; Occhiuto, Marco; Pepe, Jessica. - In: MINERVA ENDOCRINOLOGY. - ISSN 2724-6116. - 47:4(2022), pp. 437-448. [10.23736/S2724-6507.21.03378-2]

FGF23 functions and disease

Cipriani, Cristiana
Primo
;
Minisola, Salvatore;Colangelo, Luciano
Conceptualization
;
DE Martino, Viviana;Ferrone, Federica;Biamonte, Federica;Danese, Vittoria;Sonato, Chiara;Santori, Rachele;Occhiuto, Marco;Pepe, Jessica
2022

Abstract

The main function of fibroblast growth factor 23 (FGF23) is the regulation of phosphate metabolism through its action on the sodium-dependent phosphate cotransporters in the proximal renal tubules. Additionally, FGF23 interacts with vitamin D and parathyroid hormone in a complex metabolic pathway whose detailed mechanisms are still not clear in human physiology and disease. More recently, research has also focused on the understanding of mechanisms of FGF23 action on organs and system other than the kidneys and bone, as well as on its interaction with other metabolic pathways. Collectively, the new evidence are successfully used for the clinical evaluation and management of FGF23-related disorders, for whom which new therapies with many potential applications are now available.
2022
FGF23; phosphate; physiology; pathophysiology
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
FGF23 functions and disease / Cipriani, Cristiana; Minisola, Salvatore; Colangelo, Luciano; DE Martino, Viviana; Ferrone, Federica; Biamonte, Federica; Danese, Vittoria; Sonato, Chiara; Santori, Rachele; Occhiuto, Marco; Pepe, Jessica. - In: MINERVA ENDOCRINOLOGY. - ISSN 2724-6116. - 47:4(2022), pp. 437-448. [10.23736/S2724-6507.21.03378-2]
File allegati a questo prodotto
File Dimensione Formato  
Cipriani_FGF23 _2022.pdf

solo gestori archivio

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 5.5 MB
Formato Adobe PDF
5.5 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1577790
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact